Abstract 1717: MAP4K1 inhibition enhances immune cell activation and anti-tumor immunity in preclinical tumor models
Faia, Kerrie, Toso, Alberto, Fetalvero, Kristina, Roche, Marly, Bench, Steven, O'Hearn, Erin, Cao, Qiongfang, Bright, Kerry-Ann, Paduraru, Debora, Romagnani, Andrea, Weng, Weifan, Zimmermann, Tina, Burke, Michael, Close, Joshua, Green, Luke, Kim, Joseph, Miduturu, Chandra, Ribeiro, Alison, Bacac, Marina, Herter, Sylvia, Perola, Emanuele, Sheets, Michael, Eckmann, Jan, Heidkamp, Gordon, Traore, Tary, Gerson, Erik, Woessner, Rich, Wolter, Carsten, Scheuplein, Felix, Perez, Nisha, LaBranche, Timothy, Silva, Grace, Ye, Chaoyang, Utt, Caitlin, Gross, Stefan, Bischoff, James R., Dorsch, Marion, Guzi, Tim, Hoeflich, Klaus, Brubaker, Jason
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article